ORPOF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - OSE Immunotherapeutics SA

Watchlist Manager

Watchlist

Price: 11.6 USD Market Closed

Market Cap: $273.3m

	OSE Immunotherapeutics SA OTC:ORPOF	FR
3	3i Group PLC XMUN:IGQ5	UK
	Max Resource Corp OTC:MXROF	CA

Profitability Summary

OSE Immunotherapeutics SA's profitability score is 12/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1.359%

Negative 3Y Average Operating Margin

-777%

Declining Operating Margin

-811% > -1.359%

Negative Net Margin

-1.401%

Negative 3Y Average Net Margin

-781%

Declining Net Margin

-769% > -1.401%

Negative Free Cash Flow Margin

-1.268%

Negative 3Y Average Free Cash Flow Margin

-744%

Declining Free Cash Flow Margin

-784% > -1.268%

Negative ROE

-82%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-3%

Declining ROIC

-51% > -70%

View All

Hide

Collapse

12 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.